[Oxaliplatin: preclinical in vitro studies].
Marchetti
P
P
Oncologia Medica, Dipartimento di Medicina Sperimentale, Università degli Studi, L'Aquila.
Carlo
G
G
Cappellini
A
A
Porzio
G
G
Ricevuto
E
E
Cannita
K
K
Ficorella
C
C
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003514:Cyclohexylamines / Q000378:metabolism; D004273:DNA, Neoplasm / Q000187:drug effects*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D000077150:Oxaliplatin; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D003514:Cyclohexylamines; D004273:DNA, Neoplasm; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; C030435:1,2-cyclohexanediamine